Department of Biotechnology had announced the Data Driven Research to Eradicate TB – “Dare2eraD TB” program on World TB day. Indian TB Knowledge (InTBK) Hub- Webinar Series is being organised under this umbrella program every month with the aim to discuss challenges and exchange ideas; carry forward open innovations between all TB stakeholders and Create Academia- Industry connect. The 2nd webinar under the series organised on 25th April 2022, was on- “TB drug pipeline- Where we stand and what new can be done?” with Dr. Dhiraj Kumar & Dr. Vasan Sambandamurthy as the invited speakers.
Dr. Dhiraj Kumar is Group Leader of the Cellular Immunology Group at International Centre for Genetic Engineering and Biotechnology, New Delhi. He is the recipient of the prestigious S. Ramachandran National Bioscience Award and the Shanti Swarup Bhatnagar Award. Dr. Kumar is Fellow of The National Academy of Science and has over 40 peer reviewed publications to his name including in journals such as Cell, Autophagy and JBC.
Dr. Vasan Sambandamurthy is Senior Vice President, Global Operations at Bugworks. He has over 20 years of drug discovery and vaccine experience at Novartis, AstraZeneca, Syngene, and Biocon. Dr. Vasan has over 50 publications in international journals including Nature Medicine, Nature Immunology, Nature Communications and is also a co-inventor on 4 patents.